Biohaven Reports Third-Quarter Loss of $129.3 Million
Valid market news retained in the public archive without immediate LiveCast distribution.
Story updates
08:03:58 PM UTC
SquawkNews
Biohaven 3Q Loss/Shr 86c >BHVN
08:05:15 PM UTC
SquawkNews
Biohaven reported Q3 2026 net loss of $129.3M ($0.86/sh) and cash of ~$164.0M at 9/30. It received $80.0M from Ono on Oct. 20 and expects $350.0M from SK Biopharmaceuticals upon closing.Material DetailsContext by AI AnalystThis is a mid-cycle update combining quarterly loss metrics with sizable par…
08:13:59 PM UTC
SquawkNews
Biohaven Ltd. reported a comprehensive loss of $129.3 million and a net loss of $129.28 million for 2026, with diluted loss per share of $0.86. Compared with 2025, the reported losses narrowed, while loss per share improved.Financial Highlights¹ Reported as “Comprehensive loss”. ² Reported as “Net…